STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 71 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $11,374,000 | -54.5% | 2,350,000 | 0.0% | 0.10% | -42.0% |
| Q4 2019 | $24,981,000 | +4.3% | 2,350,000 | +2.2% | 0.17% | -6.6% |
| Q3 2019 | $23,943,000 | +4.2% | 2,300,000 | +53.3% | 0.18% | +21.5% |
| Q2 2019 | $22,980,000 | -10.6% | 1,500,000 | -25.0% | 0.15% | -22.8% |
| Q1 2019 | $25,700,000 | +95.0% | 2,000,000 | +68.4% | 0.19% | +65.0% |
| Q3 2017 | $13,181,000 | +23.8% | 1,187,500 | +2.6% | 0.12% | +5.4% |
| Q2 2017 | $10,649,000 | +6.7% | 1,157,500 | -0.9% | 0.11% | +0.9% |
| Q1 2017 | $9,982,000 | +262.3% | 1,167,500 | +353.4% | 0.11% | +243.8% |
| Q4 2016 | $2,755,000 | -53.9% | 257,500 | -61.9% | 0.03% | -59.5% |
| Q3 2015 | $5,971,000 | -24.6% | 676,162 | +0.5% | 0.08% | -25.5% |
| Q2 2015 | $7,916,000 | -18.7% | 672,562 | 0.0% | 0.11% | -25.4% |
| Q1 2015 | $9,732,000 | +500.4% | 672,562 | +608.0% | 0.14% | +545.5% |
| Q4 2014 | $1,621,000 | +36.9% | 95,000 | 0.0% | 0.02% | +15.8% |
| Q3 2014 | $1,184,000 | -15.1% | 95,000 | 0.0% | 0.02% | -5.0% |
| Q2 2014 | $1,394,000 | -27.9% | 95,000 | 0.0% | 0.02% | -47.4% |
| Q1 2014 | $1,934,000 | +3.9% | 95,000 | 0.0% | 0.04% | -2.6% |
| Q4 2013 | $1,862,000 | -30.3% | 95,000 | +61.0% | 0.04% | -29.1% |
| Q3 2013 | $2,672,000 | -17.0% | 59,000 | -56.3% | 0.06% | -11.3% |
| Q2 2013 | $3,218,000 | – | 135,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|